Merck Comvax Promos Cited For Implying Dosing Problems With GSK’s Pediarix
Executive Summary
CBER's Advertising & Promotional Labeling Branch is citing Merck for implying that GlaxoSmithKline's Pediarix would not be compliant with recommended dosing schedules if vaccinations are delayed